With the loss of VEGFR‐2 expression, ECs convert to a VEGF‐independent state for the maintenance of their growth and survival in glioma, leading to the resistance of ECs to anti‐VEGF treatment.122. This evidence concerns the gene VEGFA and central nervous system cancer.